Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
Edward Rockenstein, Silke Nuber, Cassia Overk, et al.
Brain (2014) Vol. 137, Iss. 5, pp. 1496-1513
Open Access | Times Cited: 213

Showing 1-25 of 213 citing articles:

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid
Mohammad Shahnawaz, Takahiko Tokuda, Masaaki Waragai, et al.
JAMA Neurology (2016) Vol. 74, Iss. 2, pp. 163-163
Open Access | Times Cited: 384
Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders
Martin Ingelsson
Frontiers in Neuroscience (2016) Vol. 10
Open Access | Times Cited: 339
Determinants of dopaminergic neuron loss in Parkinson's disease
D. James Surmeier
FEBS Journal (2018) Vol. 285, Iss. 19, pp. 3657-3668
Open Access | Times Cited: 338
Synaptopathies: synaptic dysfunction in neurological disorders – A review from students to students
Katarzyna Łepeta, Mychael V. Lourenco, Barbara Schweitzer, et al.
Journal of Neurochemistry (2016) Vol. 138, Iss. 6, pp. 785-805
Open Access | Times Cited: 314
Dementia with Lewy bodies and Parkinson’s disease-dementia: current concepts and controversies
K. A. Jellinger
Journal of Neural Transmission (2017) Vol. 125, Iss. 4, pp. 615-650
Closed Access | Times Cited: 231
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease
Nour K. Majbour, Nishant N. Vaikath, Karin D. van Dijk, et al.
Molecular Neurodegeneration (2016) Vol. 11, Iss. 1
Open Access | Times Cited: 230
Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations
Hong‐yu Li, Ahrom Ham, C. Thong, et al.
Autophagy (2018) Vol. 15, Iss. 1, pp. 113-130
Open Access | Times Cited: 192
Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein
Hazel Hall‐Roberts, David R. Brown
Biomolecules (2015) Vol. 5, Iss. 2, pp. 282-305
Open Access | Times Cited: 190
Structure, function and toxicity of alpha‐synuclein: the Bermuda triangle in synucleinopathies
Anna Villar‐Piqué, Tomás Lopes da Fonseca, Tiago F. Outeiro
Journal of Neurochemistry (2015) Vol. 139, Iss. S1, pp. 240-255
Open Access | Times Cited: 190
α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
Iryna Prots, Janina Grosch, Razvan-Marius Brazdis, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 30, pp. 7813-7818
Open Access | Times Cited: 190
Microglia as modulators of exosomal alpha-synuclein transmission
Yun Xia, Guoxin Zhang, Chao Han, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 3
Open Access | Times Cited: 179
The Role of α-Synuclein Oligomers in Parkinson’s Disease
Xiaoyu Du, Xi-xiu Xie, Rui‐tian Liu
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8645-8645
Open Access | Times Cited: 167
Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA)
Philip Wing‐Lok Ho, Chi-Ting Leung, Huifang Liu, et al.
Autophagy (2019) Vol. 16, Iss. 2, pp. 347-370
Open Access | Times Cited: 162
Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular α-synuclein transfer
Ruth E. Musgrove, Michael Helwig, Eun-Jin Bae, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3738-3753
Open Access | Times Cited: 153
Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
Roberta Cascella, Alessandra Bigi, Nunilo Cremades, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 70
Alpha Synuclein: Neurodegeneration and Inflammation
Gianluigi Forloni
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5914-5914
Open Access | Times Cited: 57
Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson’s Disease-like Dementia
Patrick Ejlerskov, Jeanette Göransdotter Hultberg, Jun‐Yang Wang, et al.
Cell (2015) Vol. 163, Iss. 2, pp. 324-339
Open Access | Times Cited: 175
Impaired intracellular trafficking defines early Parkinson's disease
Benjamin H.M. Hunn, Stephanie J. Cragg, J. Paul Bolam, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 3, pp. 178-188
Open Access | Times Cited: 169
Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease
Eleonora Carboni, Paul Lingor
Metallomics (2015) Vol. 7, Iss. 3, pp. 395-404
Open Access | Times Cited: 144
Epigenetics of dementia: understanding the disease as a transformation rather than a state
Bryan Maloney, Debomoy K. Lahiri
The Lancet Neurology (2016) Vol. 15, Iss. 7, pp. 760-774
Closed Access | Times Cited: 136
Ade novocompound targeting α-synuclein improves deficits in models of Parkinson’s disease
Wolfgang Wrasidlo, Igor F. Tsigelny, D. L. Price, et al.
Brain (2016) Vol. 139, Iss. 12, pp. 3217-3236
Open Access | Times Cited: 132
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology
Nishant N. Vaikath, Nour K. Majbour, Katerina E. Paleologou, et al.
Neurobiology of Disease (2015) Vol. 79, pp. 81-99
Closed Access | Times Cited: 128
How specific are the conformation-specific α-synuclein antibodies? Characterization and validation of 16 α-synuclein conformation-specific antibodies using well-characterized preparations of α-synuclein monomers, fibrils and oligomers with distinct structures and morphology
Senthil T. Kumar, Somanath Jagannath, Cindy François, et al.
Neurobiology of Disease (2020) Vol. 146, pp. 105086-105086
Open Access | Times Cited: 127
The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson’s disease
Jason Schapansky, Jonathan D. Nardozzi, Matthew J. LaVoie
Neuroscience (2014) Vol. 302, pp. 74-88
Open Access | Times Cited: 126
Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson’s disease
Paula Garcia‐Esparcia, Karina Hernández‐Ortega, Anusha Koneti, et al.
Acta Neuropathologica Communications (2015) Vol. 3, Iss. 1
Open Access | Times Cited: 101
Page 1 - Next Page

Scroll to top